{"BXP": {"Ticker": "BXP", "Company": "Boston Properties", "Sector": "Real Estate", "Updated": "2022-08-04", "Rating": [{"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "SMBC Nikko", "Rating_Change": "Outperform to Neutral", "Target_Change": "$93"}, {"Date": "2022-07-28", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$120 to $100"}, {"Date": "2022-06-23", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$108"}], "Score": -0.67, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Credit Suisse", "SMBC Nikko", "Piper Sandler"], "Price_Target": 100.33}, "CRL": {"Ticker": "CRL", "Company": "Charles River Laboratories", "Sector": "Health Care", "Updated": "2022-08-04", "Rating": [{"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$350 to $250"}, {"Date": "2022-05-24", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": ""}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Morgan Stanley", "Guggenheim"], "Price_Target": 250.0}, "QRVO": {"Ticker": "QRVO", "Company": "Qorvo", "Sector": "Information Technology", "Updated": "2022-08-04", "Rating": [{"Date": "2022-08-04", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$108 to $100"}, {"Date": "2022-07-11", "Rating": "Downgrade", "Organization": "Cowen", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$150 to $108"}, {"Date": "2022-06-29", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$125 to $95"}], "Score": -1.33, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Cowen", "BofA Securities"], "Price_Target": 101.0}, "SO": {"Ticker": "SO", "Company": "Southern Company", "Sector": "Utilities", "Updated": "2022-08-04", "Rating": [{"Date": "2022-08-04", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$76 to $87"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["UBS"], "Price_Target": 87.0}, "UAA": {"Ticker": "UAA", "Company": "Under Armour (Class A)", "Sector": "Consumer Discretionary", "Updated": "2022-08-04", "Rating": [{"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$12 to $10"}, {"Date": "2022-07-26", "Rating": "Resumed", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$10"}, {"Date": "2022-07-11", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$20 to $10"}, {"Date": "2022-06-21", "Rating": "Downgrade", "Organization": "Cowen", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$13 to $10"}, {"Date": "2022-05-23", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$19 to $10"}, {"Date": "2022-05-19", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$14 to $11"}], "Score": -1.17, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Morgan Stanley", "Jefferies", "Piper Sandler", "Cowen", "Robert W. Baird", "Citigroup"], "Price_Target": 10.17}}